Margo R. Roberts, Chief Scientific Officer at Kite Pharma, Inc. (KITE), sold 6,145 shares at $60.15 ($374K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
Scheduled sale ($374k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.15 | 1,556 | $94K | 25.0% |
| 2 | $60.99 | 3,439 | $210K | 56.0% |
| 3 | $61.65 | 1,150 | $71K | 18.9% |
| Total | $60.90 avg | 6,145 | $374K | 100% |
| Filing → |
| KITE | SELL | 2016-02-16 | $1.2M | — | Filing → |
| KITE | SELL | 2016-01-19 | $339K | — | Filing → |
| KITE | SELL | 2015-12-17 | $392K | — | Filing → |